(Q36833511)

English

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis

scientific article published on 28 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

0 references

1 reference

Europe PubMed Central

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis (English)

1 reference

Europe PubMed Central

16 August 2017

HIV transmission

0 references

vertical transmission

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Marie-Louise Newell

2

1 reference

Europe PubMed Central

16 August 2017

Christine Rouzioux

9

object named as

Christine Rouzioux

0 references

Philippe Van de Perre

8

object named as

Philippe Van de Perre

0 references

Valeriane Leroy

object named as

Valériane Leroy

7

0 references

François Dabis

10

object named as

François Dabis

1 reference

Europe PubMed Central

16 August 2017

Rodolphe Thiébaut

5

object named as

Rodolphe Thiebaut

1 reference

Europe PubMed Central

16 August 2017

Didier K Ekouevi

3

object named as

Didier K Ekouevi

1 reference

Europe PubMed Central

16 August 2017

Marie-Laure Chaix

4

object named as

Marie-Laure Chaix

1 reference

Europe PubMed Central

16 August 2017

1

object named as

Elise Arrivé

1 reference

Europe PubMed Central

16 August 2017

Ghent Group on HIV in Women and Children

11

object named as

Ghent Group on HIV in Women and Children

1 reference

Europe PubMed Central

16 August 2017

author name string

Bernard Masquelier

6

1 reference

Europe PubMed Central

16 August 2017

publication date

28 May 2007

1 reference

Europe PubMed Central

16 August 2017

International Journal of Epidemiology

1 reference

Europe PubMed Central

16 August 2017

36

1 reference

Europe PubMed Central

16 August 2017

1009-1021

1 reference

Europe PubMed Central

16 August 2017

5

1 reference

Europe PubMed Central

16 August 2017

HIV-1/AIDS and maternal and child health in Africa

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Indirect comparisons of competing interventions

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

HIV-1 subtype distribution and the problem of drug resistance

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

How should meta-regression analyses be undertaken and interpreted?

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.1093%2FIJE%2FDYM104

21 January 2018

Identifiers

10.1093/IJE/DYM104

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36833511&oldid=1743246284"